Exploiting bacterial DNA gyrase as a drug target: current state and perspectives
DNA gyrase is a type II topoisomerase that can introduce negative supercoils into DNA at the expense of ATP hydrolysis. It is essential in all bacteria but absent from higher eukaryotes, making it an attractive target for antibacterials. The fluoroquinolones are examples of very successful gyrase-ta...
Main Authors: | Collin, Frédéric, Karkare, Shantanu, Maxwell, Anthony |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer-Verlag
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189412/ |
Similar Items
-
The role of Ca2+ in the activity of Mycobacterium tuberculosis DNA gyrase
by: Karkare, Shantanu, et al.
Published: (2012) -
The Naphthoquinone Diospyrin Is an Inhibitor of DNA Gyrase with a Novel Mechanism of Action*
by: Karkare, Shantanu, et al.
Published: (2013) -
Fragments of the Bacterial Toxin Microcin B17 as Gyrase Poisons
by: Collin, Frédéric, et al.
Published: (2013) -
DNA Gyrase Is the Target for the Quinolone Drug Ciprofloxacin in Arabidopsis thaliana*
by: Evans-Roberts, Katherine M., et al.
Published: (2016) -
High-throughput assays for DNA gyrase and other topoisomerases
by: Maxwell, Anthony, et al.
Published: (2006)